中国寄生虫学与寄生虫病杂志 ›› 2026, Vol. 44 ›› Issue (2): 266-270.doi: 10.12140/j.issn.1000-7423.2026.02.017

• 论著 • 上一篇    下一篇

内科驱虫联合胸腔镜手术治疗儿童难治性并殖吸虫性胸腔包裹性积液:单中心15例经验与术式探讨

王洁*(), 龚胜, 高一   

  1. 成都市公共卫生临床医疗中心四川成都 610000
  • 收稿日期:2025-11-10 修回日期:2026-01-09 出版日期:2026-04-30 发布日期:2026-04-21
  • 作者简介:王洁,女,本科,主治医师,从事儿童寄生虫病防治研究。E-mail: 1025244664@qq.com
    作者贡献

    王洁负责数据整理分析和论文撰写、修改,龚胜、高一负责数据收集、整理。

  • 基金资助:
    重大传染病全程智慧管理平台研发及应用(cstc2020jscx-cylhX0001)

Combined treatment of deworming and thoracoscopic surgery for refractory pediatric paragonimiasis-induced encapsulated pleural effusions: a single-center experience of 15 cases and discussion on surgical protocols

WANG Jie*(), GONG Sheng, GAO Yi   

  1. Clinical Medical Center of Public Health of Chengdu, Chengdu 610000, Sichuan, China
  • Received:2025-11-10 Revised:2026-01-09 Online:2026-04-30 Published:2026-04-21
  • Contact: * E-mail: 1025244664@qq.com
  • Supported by:
    Research and Development of a Full-Process Intelligent Management Platform for Major Infectious Diseases and Its Application(cstc2020jscx-cylhX0001)

摘要:

目的 探讨吡喹酮内科驱虫联合胸腔镜手术外科干预对儿童难治性并殖吸虫性胸腔包裹性积液的临床疗效、手术时机选择及治疗价值。方法 回顾性分析2015年1月—2025年1月成都市公共卫生临床医疗中心收治的15例并殖吸虫性胸腔包裹性积液手术患儿病例。所有患儿术前经吡喹酮初步治疗,剂量按75 mg/(kg·d)计算,分3次口服,连续3 d为1个疗程,疗程间隔1个月。然后由同一组胸外科医师进行常规单孔胸腔镜手术。术后予抗生素抗感染、驱虫治疗、康复训练,并于术后1个月、3个月、6个月、12个月复查随访。结果 15例患儿中男性11例、女性4例,中位年龄为8.50(5.46,10.79)岁;临床表现均为胸肺型,其中含合并腹型7例,合并心包型3例,合并脑型1例,合并皮下结节型1例。血清呈并殖吸虫IgG抗体阳性的患儿14例,其余1例虽血清学阴性但胸膜病理确诊并殖吸虫感染。所有患儿术前胸部CT均显示存在包裹性积液伴胸膜增厚粘连,并接受吡喹酮治疗2~6个疗程。所有患儿均顺利完成胸腔镜手术,术中均见典型脓胸及纤维分隔。15例患儿术后病理标本均检出夏科-莱登结晶,其中2例查见虫体片段,1例查见虫卵。术后1个月复查,15例患儿的外周血嗜酸粒细胞绝对值由术前的3.70(1.32,8.33)× 109/L下降至术后的0.34(0.23,0.56)× 109/L(Z = -3.41,P < 0.01),嗜酸粒细胞占比由术前的33.00%(16.60%,44.70%)下降至术后的4.20%(2.10%,6.50%)(Z = -3.19,P < 0.01)。症状均缓解,影像学显示肺复张良好,无严重并发症。结论 对于内科治疗欠佳的儿童并殖吸虫性胸腔包裹性积液,联合胸腔镜手术治疗可有效清除病灶,促进肺复张,并能显著逆转机体的嗜酸粒细胞炎症反应。

关键词: 并殖吸虫病, 胸腔包裹性积液, 儿童, 胸腔镜手术, 吡喹酮

Abstract:

Objective To evaluate the clinical efficacy, surgical timing, and therapeutic value of deworming with praziquantel in combination with thoracoscopic surgery for treatment of pediatric refractory paragonimiasis-induced encapsulated pleural effusions. Methods The medical records of 15 children with paragonimiasis-induced encapsulated pleural effusions who underwent surgical treatment in Public Health Clinical Center of Chengdu from January 2015 to January 2025 were retrospectively analyzed. All cases received initial treatment with praziquantel pre-surgery at a dose of 75 mg/(kg·d), divided into 3 oral doses, for 3 consecutive days as one course of treatment, with an interval of one month between each course. Then, routine single port thoracoscopic surgery was performed a group of thoracic surgeons. Postoperative antibiotics administration, deworming, and rehabilitation training were given, and follow-up re-examinations were performed at 1, 3, 6, and 12 months post-surgery. Results The 15 children included 11 males and 4 females, with a median age of 8.50 (5.46, 10.79) years, and all cases had a thoracic-pulmonary type of paragonimiasis, including 7 cases complicated by abdominal type, 3 cases complicated by pericardial type, one case complicated by cerebral type, and one case complicated by subcutaneous nodule type. There were 14 children tested positive for serum IgG antibodies against Paragonimus, and the other one case was definitively diagnosed with paragonimiasis by pleural pathology despite sero-negativity. Preoperative chest CT scans displayed encapsulated effusions with pleural thickening and adhesions among all children, and 2 to 6 courses of treatment with praziquantel were given. All cases successfully completed thoracoscopic surgery, and typical empyema and fibrous septa were observed during the operation. Charcot-Leyden crystals were found in postoperative pathological specimens from 15 children, including parasite fragments seen in 2 cases and parasite eggs in one case. Routine blood tests at one-month post-surgical follow-up revealed that the absolute value of peripheral blood eosinophils in decreased from 3.70 (1.32, 8.33) × 109/L pre-surgery to 0.34 (0.23, 0.56) × 109/L post-surgery among all 15 children (Z = -3.41, P < 0.01), and eosinophils percentage decreased from 33.00% (16.60%, 44.70%) pre-surgery to 4.20% (2.10%, 6.50%) post-surgery (Z = -3.19, P < 0.01). All symptoms were relieved, and imaging showed good lung recruitment and no serious complications. Conclusion Combined treatment of deworming and thoracoscopic surgery may effectively remove lesions, promote lung recruitment and remarkably reverse host eosinophilic inflammation among children with paragonimiasis-induced encapsulated pleural effusions and unsatisfactory efficacy of medical treatment.

Key words: Paragonimiasis, Encapsulated pleural effusion, Child, Thoracoscopic surgery, Praziquantel

中图分类号: